
Delhi High Court Allows Sale of Zydus’s Nivolumab Biosimilar Ahead of Patent Expiry
Previous articleUrgent Drug Safety Alert : Telangana Drug Authorities Warn Public to Stop Using Almont-Kid Syrup
Next article India Moves Closer to Affordable Weight-Loss Therapy as Sun Pharma Wins DCGI Nod for Semaglutide
